MDLinx Family Medicine stands out from other primary care literature review services because of our dedication to keeping our members current in less time. On a daily basis, receive an email with just the ‘headlines’ covering everything important that published in your specialty in the past 24 hours. Or, choose to Focus On the top articles published in the hottest topics in primary care, such as heart failure, depression, diabetes mellitus, eczema/psoriasis, infectious diseases, rheumatoid arthritis, COPD, and many more.
Additional bonus content is also available on this page, including clinical pearls from The Smartest Family Physician, a daily quiz competition from the editors of MDLinx Internal Medicine in collaboration with the Cleveland Clinic Center for Continuing Education. Additionally, enjoy the can’t-miss articles highlighted by our own physician editor, D. Scott Cunningham, MD, PhD.
Your Unread Messages in Family Medicine
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Outcome in MI patients with hyponatremia
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Melanoma Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1 Gender differences in correlates of colorectal cancer screening among black medicare beneficiaries in Baltimore Cancer Epidemiology, Biomarkers & Prevention, May 24, 2013 Review Article
2 Food choice and nutrient intake amongst homeless people Journal of Human Nutrition and Dietetics, May 24, 2013 Clinical Article
3 The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis British Journal of Cancer, May 24, 2013 Evidence Based Medicine
4 Effect of lifetime alcohol consumption on the histologic severity of Non-Alcoholic Fatty Liver Disease Liver International, May 24, 2013 Clinical Article
5 Evaluation of the effect of blackcurrant products on gut microbiota and on markers of risk for colon cancer in humans Phytotherapy Research, May 24, 2013 Clinical Article
6 Reach, usage, and effectiveness of a medicaid patient navigator intervention to increase colorectal cancer screening, cape fear, North Carolina, 2011 Full Text Preventing Chronic Disease, May 24, 2013 Review Article
7 Esophagitis with eosinophil infiltration associated with congenital esophageal atresia and stenosis International Archives of Allergy and Immunology, May 24, 2013 Clinical Article
8 Current status of core and advanced adult gastrointestinal endoscopy training in Canada: Survey of existing accredited programs, Canadian Journal of Gastroenterology, May 24, 2013 Review Article
9 Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients Hepatology, May 24, 2013 Clinical Article
10 Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value Full Text PLoS Medicine, May 24, 2013
11 Characterization of Hepatitis B virus genotypes and quantitative Hepatitis B surface antigen titres in North American tertiary referral liver centres Liver International, May 24, 2013 Clinical Article
12 A UK retrospective observational study of clinical outcomes and healthcare resource utilisation of infliximab treatment in Crohns disease Alimentary Pharmacology and Therapeutics, May 24, 2013 Clinical Article
13 Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab British Journal of Cancer, May 24, 2013 Review Article
14 Impact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patients Digestive and Liver Diseases, May 24, 2013 Clinical Article
15 Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus Journal of Hepatology, May 24, 2013 Clinical Article
16 Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients Journal of Hepatology, May 24, 2013 Clinical Article
17 Effect of aspirin cessation before endoscopy in Japanese patients with low-dose-aspirin-associated gastroduodenal mucosal injury United European Gastroenterology Journal, May 24, 2013 Clinical Article
18 Helicobacter pylori infection and normal colorectal mucosa - adenomatous polyp - adenocarcinoma sequence: a meta-analysis of 27 case-control studies Colorectal Disease, May 24, 2013 Clinical Article
19 Water sanitation, access, use and self-reported diarrheal disease in rural Honduras Full Text Rural and Remote Health, May 24, 2013 Review Article
20 Chronic use of PPI and h2 antagonists decreases the risk of pouchitis after IPAA for Ulcerative Colitis Journal of Gastrointestinal Surgery, May 24, 2013 Clinical Article
In a 12-week randomized, controlled trial, ingestion of a vitamin D-fortified yogurt (170 mg calcium + 500 IU vitamin D/250 mL; n=50) twice daily decreased markers of inflammation compared with placebo yogurt (170 mg calcium; n=50). Compared with baseline measures, the 25(OH)D levels were increased and the TNF-alpha, IL-6, hsCRP, SAA, and IL-10 levels were decreased in the group supplemented with vitamin D compared with the group that received placebo.
Read the article summaryResearchers at the University of Palermo conducted a study involving 9109 subjects with a mean follow-up of 6.2 years which showed that the subjects who adhered to a Mediterranean diet had increased dietary fiber, decreased total dietary fat, and an increased intake of monosaturated-to-saturated fats. Further, the incidence of diabetes, cardiovascular events, and all-cause mortality was lower in the subjects who followed a Mediterranean diet.
Read the article summaryBased on a retrospective study conducted at the Federico II University (Naples), researchers have concluded that treatment of patients (n=84) with relapsing-remitting MS natalizumab for 12-24 months resulted in a greater reduction in disease activity (annualized relapse rate, .24 vs. .55, respectively) and disability progression than patients treated with INF-? 1a. The number of contrast-enhancing lesions was also less in the natalizumab-treated group.
Read the article summaryIndexed Journals in Family Medicine: American Family Physician, Archives of Family Med, Annals of Family Med more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close